Janux Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $36.1M | $380.4M | $19.2M |
| FY2024 | $38.7M | $1.06B | $430.6M |
| FY2025 | $44.7M | $1.00B | $52.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $36.1M | $380.4M | $19.2M |
| FY2024 | $38.7M | $1.06B | $430.6M |
| FY2025 | $44.7M | $1.00B | $52.3M |